Translating the Why WAIT Toolkit for Primary Care Practie

描述（由申请人提供）：翻译Why WAIT工具包用于初级保健实践将适应Why WAIT计划的行为干预部分，并评估在初级保健实践中实施它的可行性。主要目标是将目前非常成功的Why WAIT项目的一个组成部分转化为一种模式，可以广泛传播到初级保健机构，在美国，超过85%的糖尿病患者接受医疗保健，并评估在该机构实施适应性项目的可行性。目标1项目适应：将成功的Why WAIT项目的行为治疗部分转化为初级保健实践（PCP），为患者和提供者提供适当的交付方法和信息。目标2可行性评估：通过项目评估和对提供者和患者的定性研究，评估在初级保健环境中实施适应性成分的可行性。目标3：为全面评估设计随机对照试验：完成随机对照试验的研究设计，并招募足够的初级保健诊所进行完全改编的Why WAIT计划的随机对照试验。在成功完成拟议目标后，我们将能够调整整个计划，并使用严格的集群随机试验来充分测试它，以最大限度地提高普遍性和最大限度地减少偏差。人际接触与基于媒体支持的创新结合将产生“为什么等待”计划，这将对pcp非常有用，在已知的限制条件下运作，如时间和资源。与pcp和糖尿病患者进行定性深入讨论，将为“为什么等待”项目的翻译提供信息，以解决这一受众面临的需求和障碍。这将导致pcp有效地利用一个项目来达到更大比例的糖尿病人群，并将通过减肥和糖尿病管理比专业诊所的项目产生更大的公共卫生影响。这项工作的最终结果将增加为患者提供管理其疾病的工具的机会，从而降低2型糖尿病的死亡率和发病率。

DESCRIPTION (provided by applicant): Translating the Why WAIT Toolkit for Primary Care Practice will adapt the behavioral intervention component of the Why WAIT program and evaluate the feasibility of implementing it in primary care practices. The primary goal is to translate one component of the current and highly successful Why WAIT program into a model that can be widely disseminated to the primary care setting, where more than 85% of patients with diabetes receive their health care in the US and to evaluate the feasibility of implementing the adapted program in that setting. The specific aims are: Aim 1 Program Adaptation: Translate the behavioral therapy component of the successful Why WAIT program to primary care practices (PCP) with appropriate delivery approaches and messaging for both patients and providers. Aim 2 Feasibility assessment: Evaluate the feasibility of implementing the adapted component in primary care setting through program evaluation and qualitative research with providers and patients. Aim 3 Design of randomized trial for full scale evaluation: Finalize study design of the randomized controlled trial and recruit sufficient primary care practice sites for a randomized controlled trial of the fully adapted Why WAIT program Upon successful completion of the proposed objectives, we will be in a position adapt the entire program and to fully test it using a rigorous cluster randomized trial that maximizes generalizabity and minimizes bias. The innovative combination of interpersonal contact with media based support will result in a Why WAIT program that will be a extremely useful for PCPs, operating within known constraints, such as time and resources. The qualitative in-depth discussion with PCPs and diabetes patients, will inform the translation of the Why WAIT program to address the needs and obstacles faced by this audience. This will result in a program that will be used effectively by PCPs to reach a larger proportion of the diabetes population and will have a greater Public Health impact through weight reduction and diabetes management than programs located in specialty clinics. The final result of this effort will increase the opportunities to provide the tools to patients to manage their disease and thereby to reduce the mortality and morbidity consequences of T2DM.